Blockbusters in waiting: drug launches to watch in 2020
BMS, BioMotiv alliance generates biopharma company Anteros
Celgene gets new approval for soon-to-be-shed Otezla
AZ sells rights to three older drugs to Covis for $350m
Sales of MS and eczema drugs could top $4bn by 2022
FDA approves two biggest new drugs of 2017
But attendees warned to expect “oceanic” weather.
Janssen’s RA candidate among hot topics at EULAR